Advanced search
Publication Cover
Clinical Toxicology Volume 61, 2023 - Issue 5
Submit an article Journal homepage
517
Views
1
CrossRef citations to date
0
Altmetric
Clinical Research

The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking

John M. Raguea Rocky Mountain Poison and Drug Safety, Denver Health, Denver, CO, USAORCID Iconhttps://orcid.org/0000-0002-5854-8365View further author information
ORCID Icon,
Ming Mab Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0002-6511-3036View further author information
ORCID Icon,
Gregory Dooleyc Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USAORCID Iconhttps://orcid.org/0000-0002-3296-0300View further author information
ORCID Icon,
George Sam Wangd Department of Pediatrics, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0002-2931-3508View further author information
ORCID Icon,
Kyle Friedmana Rocky Mountain Poison and Drug Safety, Denver Health, Denver, CO, USAORCID Iconhttps://orcid.org/0000-0002-7125-4417View further author information
ORCID Icon,
Thomas K. Henthorne Department of Anesthesiology and Pharmaceutical Sciences, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0002-8993-3936View further author information
ORCID Icon,
Ashley Brooks-Russellb Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USAORCID Iconhttps://orcid.org/0000-0002-7728-8423View further author information
ORCID Icon &
Michael J. Kosnettf Department of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA;g Department of Medicine, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3599-3183View further author information
ORCID Icon show all
Pages 363-369 | Received 31 Oct 2022, Accepted 22 Jan 2023, Published online: 20 Mar 2023

References

  • Pattnaik F, Nanda S, Mohanty S, et al. Cannabis: chemistry, extraction and therapeutic applications. Chemosphere. 2022;289:133012.
  • Jastrząb A, Jarocka-Karpowicz I, Skrzydlewska E. The origin and biomedical relevance of cannabigerol. IJMS. 2022;23(14):7929.
  • ElSohly MA, Radwan MM, Gul W, et al. Phytocannabinoids: unraveling the complex chemistry and pharmacology of cannabis sativa. In: kinghorn AD, Falk H, Gibbons S editors. Phytochemistry of cannabis sativa. New York: Springer International Publishing; 2017. p. 1–36.
  • de Meijer EPM, Hammond KM. The inheritance of chemical phenotype in cannabis sativa L.(II): cannabigerol predominant plants. Euphytica. 2005;145(1-2):189–198.
  • Gul W, Gul SW, Radwan MM, et al. Determination of 11 cannabinoids in biomass and extracts of different varieties of cannabis using high-performance liquid chromatography. J AOAC Int. 2015;98(6):1523–1528.
  • Patel B, Wene D, Fan ZT. Qualitative and quantitative measurement of cannabinoids in cannabis using modified HPLC/DAD method. J Pharm Biomed Anal. 2017;146:15–23.
  • Newmeyer MN, Swortwood MJ, Barnes AJ, et al. Free and glucuronide whole blood cannabinoids’ pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users: identification of recent cannabis intake. Clin Chem. 2016;62(12):1579–1592.
  • McCartney D, Arkell TR, Irwin C, et al. Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review. Neurosci Biobehav Rev. 2021;126:175–193.
  • Karschner EL, Swortwood-Gates MJ, Huestis MA. Identifying and quantifying cannabinoids in biological matrices in the medical and legal cannabis era. Clin Chem. 2020;66(7):888–914.
  • Brooks-Russell A, Brown T, Friedman K, et al. Simulated driving performance among daily and occasional cannabis users. Accid Anal Prev. 2021;160:106326.
  • Schwope DM, Scheidweiler KB, Huestis MA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem. 2011;401(4):1273–1283.
  • Krämer M, Schäper M, Dücker K, et al. Detectability of cannabinoids in the serum samples of cannabis users: indicators of recent cannabis use? A follow‐up study. Drug Test Anal. 2021;13(9):1614–1626.
  • Huestis MA, Blount BC, Milan DF, et al. Correlation of creatinine‐and specific gravity‐normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Drug Test Anal. 2019;11(7):968–975.
  • Hidvegi E, Somogyi GP. Detection of cannabigerol and its presumptive metabolite in human urine after cannabis consumption. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2010;65(6):408–411.
  • Newmeyer MN, Swortwood MJ, Abulseoud OA, et al. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug Alcohol Depend. 2017;175:67–76.
  • Spindle TR, Cone EJ, Schlienz NJ, et al. Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial. JAMA Netw Open. 2018;1(7):e184841-e184841.
  • Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204–212.
  • Lindholst C. Long term stability of cannabis resin and cannabis extracts. Aust J Forensic Sci. 2010;42(3):181–190.
  • Bergamaschi MM, Karschner EL, Goodwin RS, et al. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws. Clin Chem. 2013;59(3):519–526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.